Related Experiment Video
Updated: Dec 6, 2025

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
GRβ Regulates Glucocorticoid Resistance in Sudden Sensorineural Hearing Loss
Xubo Chen1, Qi Zhang2, Chunping Yang1
1Department of Otolaryngology, Head and Neck Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China.
Background:
In recent years, the incidence of sudden deafness has gradually increased, with a very limited understanding of its etiology and pathogenesis. Glucocorticoids are the first choice of the treatment, but some hormone-resistant patients are not sensitive to glucocorticoid therapy. The pathogenesis is not yet known. In this study, we aim to construct the HEI-OC1 cell line stably overexpressing Glucocorticoid Receptor Beta (GRβ), and identify its exact role in the cases of glucocorticoidresistant sudden deafness.
Methods:
We used the endotoxin lipopolysaccharide-stimulated cochlear hair cells (HEI-OC1) to investigate the relationship of inflammation factor IL-2, TNF alpha, and SRp30c with the high expression GRβ. We built a stable GRβ high expression HEI-OC1 cell line and clarified its effects on the therapeutic effect of dexamethasone. MTT assay, colony formation assay, CCK-8 assay, Western blot, and RT-qPCR were utilized for characterizations.
Results:
Dexamethasone reduced the LPS-induced inflammatory response from HEI-OC1 cells (p<0.05), detected by MTT assay. Dexamethasone could protect HEI-OC1 cells, but its protective effect was weakened due to the transfection of SRp30c over-expression plasmid (p<0.05). The transfection of SRp30c over-expression plasmid in HEI-OC1 cells could elevate the expressions of GRβ (p<0.05).
Conclusion:
We clarified the mechanisms of high expression of GRβ in glucocorticoid-resistant sudden sensorineural hearing loss, and proved that the inhibition of SRp30c may act as a new treatment way of glucocorticoid-resistant sudden sensorineural hearing loss.
Insights
Sudden deafness is rising, and glucocorticoid resistance is a challenge. This study reveals that inhibiting SRp30c may offer a new treatment for glucocorticoid-resistant sudden sensorineural hearing loss by targeting GRβ expression.
Area of Science:
- Otolaryngology
- Molecular Biology
- Pharmacology
Background:
- Sudden deafness incidence is increasing, with poorly understood causes and limited treatment options for glucocorticoid-resistant cases.
- Glucocorticoids are the primary treatment, but some patients do not respond, necessitating research into alternative therapeutic strategies.
- The role of Glucocorticoid Receptor Beta (GRβ) in glucocorticoid resistance in sudden deafness is not yet fully elucidated.
Purpose of the Study:
- To construct a HEI-OC1 cell line with stable overexpression of Glucocorticoid Receptor Beta (GRβ).
- To investigate the role of GRβ in glucocorticoid-resistant sudden sensorineural hearing loss.
- To explore the relationship between inflammation factors (IL-2, TNF alpha, SRp30c) and GRβ expression in cochlear hair cells.
Main Methods:
- Utilized lipopolysaccharide-stimulated cochlear hair cells (HEI-OC1) to model inflammation.
- Established a stable GRβ high expression HEI-OC1 cell line for experimental analysis.
- Employed MTT assay, colony formation assay, CCK-8 assay, Western blot, and RT-qPCR to characterize cellular responses and gene expression.
Main Results:
- Dexamethasone treatment reduced lipopolysaccharide-induced inflammation in HEI-OC1 cells (p<0.05).
- Overexpression of SRp30c attenuated the protective effects of dexamethasone on HEI-OC1 cells (p<0.05).
- SRp30c overexpression in HEI-OC1 cells led to elevated GRβ expression (p<0.05).
Conclusions:
- Elucidated the mechanisms underlying high GRβ expression in glucocorticoid-resistant sudden sensorineural hearing loss.
- Demonstrated that SRp30c plays a role in glucocorticoid resistance.
- Identified SRp30c inhibition as a potential novel therapeutic strategy for glucocorticoid-resistant sudden sensorineural hearing loss.
Related Concept Videos
GPCR Desensitization
Desensitization and Tachyphylaxis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
GPCRs Regulate Adenylyl Cylase Activity
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

